What considerations are involved in the ethics of withholding versus withdrawing life-sustaining treatment in the ICU?

Study for the Fundamentals of Nursing Ethics and Values Test. Prepare with flashcards and multiple-choice questions, each offering hints and explanations. Get ready for your exam!

Multiple Choice

What considerations are involved in the ethics of withholding versus withdrawing life-sustaining treatment in the ICU?

Explanation:
The main idea tested here is how to approach withholding versus withdrawing life-sustaining treatment in the ICU by balancing what the patient wants, what the prognosis suggests, and what the burdens and benefits of treatment are, all within legal and institutional rules. Ethically, withholding and withdrawing are morally on the same footing when they reflect the patient’s goals of care and informed understanding of likely outcomes. The process starts with clarifying the patient’s or a legally authorized surrogate’s goals and values, then evaluating prognosis and the likely benefits and burdens of continuing or stopping treatment. This includes considering quality of life, potential suffering, and whether ongoing measures would meaningfully advance the patient’s well-being. Decisions should be made through informed discussions with the patient or surrogate, and must align with legal requirements, hospital policies, and professional guidelines. As conditions change, the plan should be revisited, and if there’s disagreement, ethics consultation or palliative care can help. Surrogates play a legitimate role in representing the patient’s wishes when the patient lacks capacity, but decisions are grounded in the patient’s values and the clinical context. Other options are not correct because they either suggest one approach is always permissible or that physician judgment alone should drive decisions, or they exclude the patient or surrogate from the process. The ethical standard is patient-centered, collaborative decision-making that respects autonomy, beneficence, non-maleficence, and legal/policy frameworks.

The main idea tested here is how to approach withholding versus withdrawing life-sustaining treatment in the ICU by balancing what the patient wants, what the prognosis suggests, and what the burdens and benefits of treatment are, all within legal and institutional rules. Ethically, withholding and withdrawing are morally on the same footing when they reflect the patient’s goals of care and informed understanding of likely outcomes. The process starts with clarifying the patient’s or a legally authorized surrogate’s goals and values, then evaluating prognosis and the likely benefits and burdens of continuing or stopping treatment. This includes considering quality of life, potential suffering, and whether ongoing measures would meaningfully advance the patient’s well-being. Decisions should be made through informed discussions with the patient or surrogate, and must align with legal requirements, hospital policies, and professional guidelines. As conditions change, the plan should be revisited, and if there’s disagreement, ethics consultation or palliative care can help. Surrogates play a legitimate role in representing the patient’s wishes when the patient lacks capacity, but decisions are grounded in the patient’s values and the clinical context.

Other options are not correct because they either suggest one approach is always permissible or that physician judgment alone should drive decisions, or they exclude the patient or surrogate from the process. The ethical standard is patient-centered, collaborative decision-making that respects autonomy, beneficence, non-maleficence, and legal/policy frameworks.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy